JPRN-jRCTs051200038已完成1 期
Development of a new cancer diagnostic method based on metabolites derived from samples before and after oral administration of 13C-labeled glucose in patients with PET-positive lung cancer : Single-arm, exploratory clinical trial
Yoshida Masaru0 个研究点目标入组 6 人开始时间: 2020年7月30日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 80age old（—）
- 性别
- All
入选标准
- •(1) Patients who are at least 20 years old and under 80 years old at the time of obtaining consent
- •(2) PET-positive primary lung cancer patients who can be surgically resected
- •(3) Patients who have given their informed consent to participate in this clinical study
排除标准
- •(1) Patients with other cancers
- •(2) Other patients judged inappropriate by the person in charge of this clinical study
研究者
相似试验
招募中
不适用
Development of cancer immune evaluation toolNeoplasmsKCT0002469Seoul Songdo Hospital500
招募中
不适用
Development of early cancer diagnosis technique using blood sample by Raman spectroscopyJPRN-UMIN000034306Showa University Koto Toyosu Hospital2,000
已完成
不适用
sing stool samples in the diagnosis of mitochondrial diseaseISRCTN15670031ewcastle upon Tyne Hospitals NHS Foundation Trust47
尚未招募
不适用
A novel method to improve the detection of cancer and metastases by peptide scanning under the protection of enzyme inhibitors: PepProtect 1NL-OMON44441Erasmus MC, Universitair Medisch Centrum Rotterdam12
已完成
不适用
A novel technique for cellular diagnosis utilizing scanning electron microscope.thoracic malignancyJPRN-UMIN000025724ational Cancer Center Hospital100